NPI: 1568609808 · AVE MARIA, FL 34142 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 01/08/2009
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 01/08/2009 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 9,474 | $1.84M |
| 2019 | 12,662 | $2.23M |
| 2020 | 14,050 | $1.91M |
| 2021 | 13,023 | $955K |
| 2022 | 5,578 | $593K |
| 2023 | 966 | $193K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 18,238 | 1,123 | $2.51M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 16,611 | 719 | $2.29M |
| J1270 | Injection, doxercalciferol, 1 mcg | 10,465 | 661 | $1.44M |
| J1756 | Injection, iron sucrose, 1 mg | 3,867 | 694 | $520K |
| A4657 | Syringe, with or without needle, each | 1,432 | 925 | $298K |
| 85041 | 1,228 | 789 | $149K | |
| 85048 | 1,223 | 785 | $143K | |
| 83970 | 762 | 488 | $105K | |
| 83540 | 619 | 429 | $84K | |
| 82728 | 606 | 417 | $83K | |
| 83550 | 447 | 325 | $65K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 195 | 88 | $25K |
| 90674 | 18 | 12 | $5K | |
| G0008 | Administration of influenza virus vaccine | 42 | 27 | $1K |